Finland· FI-REL-REL7726
Duracef
A cefadroxil product, registered in Finland by Orion Corporation Orion Pharma. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Cefadroxil is registered in 11 of 19 countries.
Countries holding a registration under ATC J01DB05 (cefadroxil), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Cefadroxil · ATC J01DB05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Polandprice
- Spainprice
- Sweden
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefadroxil costs, country by country.
Normalised to the WHO defined daily dose (2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cefadroxil · price per daily dose (2 g)
USD · FX 28 Sept 2026
- ES Spain$1.45
The record
At a glance
Fimea (Finland)- Manufacturer
- Orion Corporation Orion Pharma
- Country
- Finland (FI)
- ATC code
- J01DB05
- ATC class
- Cefadroxil
- Defined daily dose
- 2 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
71 interactions on record for cefadroxil.
Graded by severity as the source publishes them — 12 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefadroxil · interactions on record
71 records
- 12 moderate
- 59 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- BalsalazideA07EC04moderate
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01DB05
Cefadroxil, as other registers publish it.
- CanadaAPO-CEFADROXILAPOTEX INC
- United KingdomBaxan 125mg/5ml oral suspensionBristol-Myers Squibb Pharmaceuticals Ltd
- United KingdomBaxan 250mg/5ml oral suspensionBristol-Myers Squibb Pharmaceuticals Ltd
- United KingdomBaxan 500mg capsulesWaymade Healthcare Plc
- United KingdomBaxan 500mg capsulesBristol-Myers Squibb Pharmaceuticals Ltd
- United KingdomBaxan 500mg/5ml oral suspensionBristol-Myers Squibb Pharmaceuticals Ltd
- CzechiaBIODROXILSandoz GmbH, Kundl
- CzechiaBIODROXILSandoz GmbH, Kundl
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c8eb3cef-589c-403d-adb0-51a6449b8aea GET /v1/drugs/c8eb3cef-589c-403d-adb0-51a6449b8aea?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "2",
"form": "kapseli",
"route": null,
"ddd_unit": "g",
"strength": "500 mg",
"atc_label": "kefadroksiili",
"ma_number": "8119",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL7726",
"authorised_at": "1981-03-11"
}See everything about cefadroxil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.